Relmada Therapeutics (RLMD) Insider Trading & Ownership → Crypto Pioneer Says: “The last crypto bull market has begun.” (From InvestorPlace) (Ad) Free RLMD Stock Alerts $3.64 +0.11 (+3.12%) (As of 05/14/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Relmada Therapeutics (NASDAQ:RLMD) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage18.00%Number OfInsiders Buying(Last 12 Months)4Amount OfInsider Buying(Last 12 Months)$382,104.61Number OfInsiders Selling(Last 12 Months)0 Get RLMD Insider Trade Alerts Want to know when executives and insiders are buying or selling Relmada Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address RLMD Insider Buying and Selling by Quarter Ad Gold Safe ExchangeTrump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar… Relmada Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails1/31/2024Maged ShenoudaCFOBuy6,875$4.06$27,912.50 1/31/2024Sergio TraversaCEOBuy27,460$4.00$109,840.00 1/30/2024Chuck EnceInsiderBuy14,500$3.87$56,115.00 1/29/2024Maged ShenoudaCFOBuy10,800$3.65$39,420.00 1/29/2024Sergio TraversaCEOBuy31,541$3.71$117,017.11 5/23/2023Cedric O'gormanInsiderBuy10,000$3.18$31,800.00 (Data available from 1/1/2013 forward) RLMD Insider Trading Activity - Frequently Asked Questions Who is on Relmada Therapeutics's Insider Roster? The list of insiders at Relmada Therapeutics includes Cedric O'gorman, Charles J Casamento, Chuck Ence, Maged Shenouda, Paul Edward Kelly, and Sergio Traversa. Learn more on insiders at RLMD. What percentage of Relmada Therapeutics stock is owned by insiders? 18.00% of Relmada Therapeutics stock is owned by insiders. Learn more on RLMD's insider holdings. Which Relmada Therapeutics insiders have been buying company stock? The following insiders have purchased RLMD shares in the last 24 months: Cedric O'gorman ($31,800.00), Chuck Ence ($56,115.00), Maged Shenouda ($67,332.50), and Sergio Traversa ($342,882.11). How much insider buying is happening at Relmada Therapeutics? Insiders have purchased a total of 156,426 RLMD shares in the last 24 months for a total of $498,129.61 bought. Which Relmada Therapeutics insiders have been selling company stock? The following insider sold RLMD shares in the last 24 months: Sergio Traversa ($306,309.56). How much insider selling is happening at Relmada Therapeutics? Insiders have sold a total of 16,012 Relmada Therapeutics shares in the last 24 months for a total of $306,309.56 sold. More Insider Trading Tools from MarketBeat Related Companies: Rezolute Insider Trades Societal CDMO Insider Trades OptiNose Insider Trades PMV Pharmaceuticals Insider Trades Allakos Insider Trades Cartesian Therapeutics Insider Trades Immunic Insider Trades Cue Biopharma Insider Trades Abeona Therapeutics Insider Trades Assertio Insider Trades Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 3 Penny Stocks That Insiders Are BuyingThe 3 Hottest Insiders Buys This Month 3 Companies Buying Back Cheap Stock LatelyPagaya Technologies: An AI Fintech That Insiders Are BuyingThe 5 Stocks Most Sold By Insiders This Year This page (NASDAQ:RLMD) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersDid Intel Just Dethrone Nvidia?Chaikin AnalyticsClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsCharles Payne Demystifies OptionsUnstoppable ProsperityRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap SniperTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressThe only AI company you should be looking atBehind the MarketsElon to Transform U.S. Economy? Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Relmada Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.